← Browse by Condition
Medical Condition

acute heart failure

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for acute heart failure sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — acute heart failure Clinical Trials

How many clinical trials are currently recruiting for acute heart failure?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for acute heart failure, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for acute heart failure?
acute heart failure research spans Phase 3 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a acute heart failure clinical trial?
Eligibility criteria for acute heart failure trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Phase 4
1
Top Sponsors
Juntendo University 1 trial
Seoul National University Bundang Hospital 1 trial
China-Japan Friendship Hospital 1 trial

Recruiting Clinical Trials

NCT05392764 Phase 3
Recruiting
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
Enrollment
444 pts
Location
Japan
Sponsor
Juntendo University
View Trial →
NCT04329234
Recruiting
Korean Heart Failure Registry III
Enrollment
10,000 pts
Location
South Korea
Sponsor
Seoul National University Bund...
View Trial →
NCT05991128 Phase 4
Recruiting
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life
Enrollment
170 pts
Location
China
Sponsor
China-Japan Friendship Hospita...
View Trial →

Related Conditions

heart failure with preserved ejection fraction (1) iron deficiencies (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology